Maine Medicine Weekly Update - February 12, 2021
(Print All Articles)

MMA Weekly State Vaccination Plan Update

As Mainers continue to combat the COVID-19 pandemic, the Maine Medical Association Board of Directors and staff is continuing our efforts to engage Maine DHHS & Maine CDC to ensure equitable access to potentially lifesaving COVID-19 vaccine doses. We hope recent meetings and plan development will soon include more independent community physicians in COVID-19 vaccination plans.

 

As Mainers continue to combat the COVID-19 pandemic, the Maine Medical Association Board of Directors and staff is continuing our efforts to engage Maine DHHS & Maine CDC to ensure equitable access to potentially lifesaving COVID-19 vaccine doses. We hope recent meetings and plan development will soon include more independent community physicians in COVID-19 vaccination plans.

The MMA Executive Committee has been working closely alongside the Maine Osteopathic Association (MOA), the Maine Primary Care Association (MePCA), and AARP on our efforts urging the state to incorporate locally owned and operated medical practices into plans to vaccinate their 70 and older patients with a prioritization on those with medical conditions that put them at greatest risk. Patients continue flooding smaller medical practice phone lines asking why their doctors cannot or will not vaccinate them.

As a result of weeks of work and brainstorming, MMA, MOA, and MePCA have jointly developed an independent medical practice collaboration template to be considered by Maine CDC for future vaccine allocation supplies for their patients. The MMA Executive Committee wishes to publicly thank Maine DHHS Senior Advisor, Lisa Letourneau, M.D., MPH, for her tireless efforts in engaging Maine’s physician community and on this and many other pandemic related challenges over the last year. Immediate Past-President Amy Madden, M.D., and MMA Board Chair, Erik Steele, D.O., played significant roles in drafting this document with Dr. Letourneau and Sally Weiss of Maine DHHS. We understand this to be a work in progress and are hoping for more flexibility as vaccine supply increases and the state develops more formal guidance for hard-to-reach populations.

Please contact MMA Director of Communications and Government Affairs, Dan Morin at dmorin@mainemed.com or by phone at 207-480-4199 for a copy, or more information about the medical practice vaccine collaboration template. The template should be used by potential community collaborations or “consortia” to propose alternative vaccine sites to the high throughput “mega-sites” if they can meet a 1000 dose/week threshold.

MMA CEO Andy MacLean was part of a regular state Vaccine Steering Committee along with colleagues from the Maine Hospital Association, the Maine Primary Care Association, and the Maine Health Care Association (nursing homes/assisted living/long term care) this week which included Maine DHHS Commissioner Jeanne Lambrew, Dr. Nirav Shah, & Governor Mills’ Senior Policy Advisor for Legislative Affairs, Beth Beausang. Discussion included the following topics.

The Week 10 order of vaccines for Maine is up slightly; an additional 1000 first doses (22,475) are expected next week. The amount does not include 4500 Moderna second doses.

Thirty-seven sites throughout Maine will receive only 100 doses. Twenty-six hospitals are scheduled to receive a total of 16,100 doses, tree independent pharmacies will receive a total of 400. Public safeties agencies will be getting 1,700 and the Houlton Band of Maliseet Health and Wellness Center, 100. The following outpatient groups can expect a total of 4,175:

Martin's Point Health Care—900

Maine Center for Cancer Medicine /dba New England Cancer Specialists—200

InterMed PA—1,275

Penobscot Community Health Care in Bangor—200

VNA Home Health and Hospice d/b/a Northern Light Home Care and Hospice—600

Spectrum Healthcare Partners—100

Greater Portland Health—100

B-Street Health Center—100

Sacopee Valley Health Center—100

York County Community Action Corporation/Nasson Health Care—100

KVHC-Brownville—100

Health Access Network - Lincoln—100

Regional Medical Center at Lubec—100

Eastport Health Care Inc. —100

Other topics discussed by the state’s Vaccine Steering Committee included:

Federal supply of vaccines

Vaccination site planning, and

Hard-to-reach groups/equity

The state received 4400 doses that were too cold around Martin Luther King weekend & it’s taken several weeks to determine that they can be used.

The state is expecting federal supply to remain the same for the next 3 weeks;

The Biden Administration is rolling out the U.S. Retail Pharmacy Program involving Walmart, CVS, Walgreens, & Cardinal. (details below)

The federal government also announced a new program for direct shipment of vaccine to federally qualified health centers (FQHCs), separate from the supply sent to states.

They are also anticipating separate federal supplies to VA, indigenous populations, DOD, perhaps others.

The U.S. CDC is working on guidance for nationwide community vaccine sites.

The U.S. CDC’s Advisory Committee on Immunization Practices (ACIP) will review the Johnson & Johnson vaccine the weekend of February 26, 2021 and emergency use authorization (EUA) could come before March.

Marshall’s in Sanford; Auburn Mall, and the Augusta Civic Center “mega-sites” could be operational by next week.

The state continues working on unified scheduling internet platform/call center that hopefully will work in unison with the existing platforms of hospitals and health systems.

The state still looking at ways to track allocation & usage in order to avoid waste and may soon issue a policy on waste which may include enforcement mechanism.

The state is continuing to develop a transportation plan aimed at hard-to-reach populations and access for those Mainers through targeted vaccination clinics.

The state likely will continue to overlap vaccine phase eligibility as it did with Phase 1a/1b in effort to keep volume up.

Federal Government Announces Vaccine Distribution Plans with Walmart/Sam’s Club in 22 states—including Maine. Walmarts and Sam's Clubs in Maine got their first shipments of the COVID vaccine Wednesday morning. Maine locations offering the vaccine to eligible populations of Mainers can be found here, along with contact information. Maine is currently vaccinating people in Phase 1a: Health care, public safety, and critical COVID-19 infrastructure personnel, and only part of Phase 1b: People age 70 and over.

The New York Times published a story this week outlining how primary care physicians have grown increasingly frustrated with their exclusion from the nation’s vaccine rollout, unable to find reliable supplies for even their eldest patients and lacking basic information about distribution planning for the shots.

Additional Vaccine Resources:

 

 

 

 

MMA Leadership & Staff Share Condolences on Passing of George Smith

It is with very heavy hearts, that the Maine Medical Association Board of Directors and staff send their condolences to retired MMA Executive Director, Gordon Smith and his entire family on his brother George Smith’s passing on Friday.

 


It is with very heavy hearts, that the Maine Medical Association Board of Directors and staff send their condolences to retired MMA Executive Director, Gordon Smith and his entire family on his brother George Smith’s passing on Friday.

The widely beloved, and renowned sportsman and author passed away Friday after a battle with ALS. Family, friends, and state officials from throughout Maine are feeling the loss and heartbreak this weekend.

Since his passing, Governor Mills has released a statement on George’s passing and the news of his death is being covered by local media.

Pioneering Maine outdoorsman George Smith dies at 72 (Portland Press Herald)

Maine sportsman George Smith dies after 4-year ALS battle (Bangor Daily News)

In her statement, Governor Mills said she was deeply saddened by his passing, stating how George, “was the very embodiment of the character of Maine: strong but kind, independent but compassionate, wise but humble.”

George was a 1970 graduate of the University of Maine, and a recipient of the Alumni Career Award, the Alumni Association’s highest honor in recognition for his work as former executive director of the Sportsman’s Alliance of Maine (SAM), and leadership efforts as a longtime advocate for Maine’s land conservation policy and the traditional use of the state’s forests and waterways.

Maine PMP to Stay with Appriss System

Director of Opioid Response for the State of Maine, Gordon Smith directly messaged various stakeholder organizations this week to inform PMP users statewide that after months of deliberations and concerns expressed by clinicians, Maine has decided to retain the use of the Appriss Prescription Monitoring Program system rather than install and transition to a new system.

 

Director of Opioid Response for the State of Maine, Gordon Smith directly messaged various stakeholder organizations this week to inform PMP users statewide that after months of deliberations and concerns expressed by clinicians, Maine has decided to retain the use of the Appriss Prescription Monitoring Program system rather than install and transition to a new system. 

Please see the message below being sent to all current PMP users (data submitters and clinicians) from Rebecca Taylor, OBH Deputy Director for Research and Evaluation. 

Please address any questions you may have to Ms. Taylor using contact information listed below. 

Dear PMP User, 

Thank you for your patience and assistance during the PMP system transition. We are writing to provide you with an important update regarding this transition.

As you know, in August 2019 Maine DHHS made the determination to transition from the Appriss PMP system to a new PMP product offered by NIC/InforME: RxGov. This decision was based upon multiple factors, including the opportunity to access enhanced federal funding and the desire to enhance PMP reporting functionality. The new NIC/RxGov PMP was subsequently offered to Maine prescribers in the fall of 2020, while the Appriss AWARxE PMP remained functional and available to prescribers. After fully exploring this opportunity over the past several months and soliciting input from Maine clinicians, Maine DHHS has made the decision to retain the Appriss AWARxE PMP due to its superior performance, particularly related to issues of data validity, functionality, and reporting. Examples of the desired functionality that remain available from the Appriss AWARxE PMP include the following: 

  • Printing of patient histories, both individual patients and groups of patients
  • Ability to automatically view the use of controlled drugs from prescribers in Maine and New Hampshire, our contiguous state
  • Robust patient matching to allow clinicians see all records associated with a single patient
  • Availability of NarxCare, a visual clinical decision support tool that allows prescribers to see overlapping prescriptions of controlled substances and assess patient risk

In making this decision, DHHS is acutely aware of the need to minimize the administrative burden to Maine prescribers. Because the Appriss PMP system has remained fully operational throughout the transition period, prescribers currently enrolled in the Appriss PMP system will not be required to make any changes in their enrollment or registration. Prescribers who are using the NIC/RxGov PMP system are encouraged to return to using the Appriss AWARxE PMP as soon as possible.

All Maine healthcare providers, whether enrolled in the Appriss system or not, will receive emails with detailed Appriss PMP login instructions beginning in the next few days. Please note that these emails will come from Appriss Health.

As part of the reversion to the Appriss AWARxE PMP system, Maine DHHS looks forward to upcoming opportunities to engage PMP users in stakeholder engagement sessions to gather feedback on potential additional needs for enhanced PMP functionality, share existing solutions offered by the Appriss, and offer information about planned enhancements for the Appriss system. More information on those opportunities will be forthcoming soon. Questions about this transition or other aspects of the Maine PMP program can be directed to the Office of Behavioral Health PMP Team at: email: PMP@maine.gov or Phone: (207) 287-2595 Option 2.

Thank you,

Rebecca A. Taylor, Deputy Director

Office of Behavioral Health


 

Next Maine CDC COVID-19 Update for Clinicians with Stephen Sears, MD scheduled for Feb 25

The calls are held bi-Weekly every 2nd and 4th Thursday of the month at 12:30 p.m., however, the meeting schedule for last week had been previously canceled. We apologize for not proving notice in advance.

 

The calls are held bi-Weekly every 2nd and 4th Thursday of the month at 12:30 p.m., however, the meeting schedule for last week had been previously canceled. We apologize for not proving notice in advance. 

The next meeting is scheduled for February 25th at 12:30 p.m. 

Join Zoom Meeting https://zoom.us/j/98624137592?pwd=UG45YnlFSW5raVlNNEdzYmt3R0Jxdz09 

Meeting ID: 986 2413 7592 

Passcode: 375263 

One tap mobile: 

+13126266799,,98624137592# US (Chicago) 

+16465588656,,98624137592# US (New York)

 

Federal Government Finalizes Purchase of 200M COVID-19 Vaccines Doses

President Biden announced this week the federal government has finalized deals to buy 200 million more COVID-19 vaccine doses from Pfizer and Moderna by the end of July, a major step to widespread national vaccination efforts to attack the current pandemic.

 

President Biden announced this week the federal government has finalized deals to buy 200 million more COVID-19 vaccine doses from Pfizer and Moderna by the end of July, a major step to widespread national vaccination efforts to attack the current pandemic.

The deal includes 100 million more doses from Pfizer/BioNTech, as well as 100 million more from Moderna. The extra doses will not be immediately available, meaning that the existing supply shortages are likely to continue in the short term. However, Dr. Fauci recently stated he thinks that by April it will be "open season" for vaccinations in the country, and anyone who wants a shot will be able to get one. That doesn’t mean everyone will be vaccinated before the summer as he added that logistically it will still take "several more months" to get the vaccine into people's arms, possibly leading to an overwhelming majority of people in the US will be vaccinated by the end of the summer.

Media reports (Bloomberg) that if the additional vaccine doses are delivered in the timeframe outlined, it “would give the U.S. enough doses for 300 million people by the end of July – a number that could increase if other vaccine candidates, such as one from Johnson & Johnson, are approved.” But the process of giving people shots “could stretch into late summer and early fall.”


US CDC: Fully Vaccinated Meeting Criteria No Longer Required to Quarantine After Exposure

The Centers for Disease Control and Prevention (CDC) has issued new guidance (02/10/21) that people who have been fully vaccinated for the coronavirus no longer need to quarantine if they are exposed to someone who is infected with COVID-19.

 

The Centers for Disease Control and Prevention (CDC) has issued new guidance (02/10/21) that people who have been fully vaccinated for the coronavirus no longer need to quarantine if they are exposed to someone who is infected with COVID-19. 

The U.S. CDC regularly updates interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States. The most recent update includes udated quarantine recommendations for vaccinated persons. Fully vaccinated persons who meet criteria will no longer be required to quarantine following an exposure to someone with COVID-19. 

Additional changes: 

· New recommendations for preventing, reporting, and managing mRNA COVID-19 vaccine administration errors. 

· Clarification on contraindications and precautions. Persons with a known (diagnosed) allergy to PEG, another mRNA vaccine component, or polysorbate, have a contraindication to vaccination. Persons with a reaction to a vaccine or injectable therapy that contains multiple components, one of which is PEG, another mRNA vaccine component or polysorbate, but in whom it is unknown which component elicited the immediate allergic reaction have a precaution to vaccination. 

· Updated information on delayed, local injection-site reactions after the first mRNA vaccine dose. These reactions are neither a contraindication or precaution to the second dose. 

· Additional information and updated recommendations for testing for TB infection. TB testing can be done before or at the same time as mRNA COVID-19 vaccination, or otherwise delayed for ≥4 weeks after the completion of mRNA COVID-19 vaccination.

 

AMA President: Physicians & Medical Societies Can Play Vital Role Advocating for Strong Public Health

American Medical Association President, Susan Bailey, M.D., writes outlines that while overcoming COVID-19 will be a significant victory, the larger campaign to rebuild our public health infrastructure will remain before us.  The COVID-19 pandemic has exposed fundamental flaws in the provision of health care across our nation and exacerbated the tremendous differences in health outcomes tied to race, income and other demographic factors.

 

American Medical Association President, Susan Bailey, M.D., writes outlines that while overcoming COVID-19 will be a significant victory, the larger campaign to rebuild our public health infrastructure will remain before us.  The COVID-19 pandemic has exposed fundamental flaws in the provision of health care across our nation and exacerbated the tremendous differences in health outcomes tied to race, income and other demographic factors. 

Read the article. 

From Dr. Bailey: 

· Health departments also play a vital role in educating the public about unexpected infectious disease threats as well as evidence-based interventions for mitigation. 

· Adequate funding is necessary to provide these services—but state public health spending has fallen 16% over the past decade. 

· Nearly 40,000 jobs at state and local public health agencies have been eliminated since the 2008 recession. 

· At the same time, federal funding for emergency preparedness and response programs administered by the Centers for Disease Control and Prevention has been slashed by 50% over the past decade. 

· Persistent disinvestment in governmental public health agencies has limited our ability to effectively respond to SARS-CoV-2 and other crises. 

· We must provide the funding required to upgrade essential functions such as public health surveillance to identify underlying causes and etiologies, which will improve our response to existing and emerging perils. 

· AMA helped shape last year’s revision of the 10 Essential Public Health Services, which were created a quarter-century ago to define the activities public health organizations should undertake in every community.

 

NEJM: The FDA’s Experience with Covid-19 Antibody Tests

Jeffrey Shuren, M.D., J.D., and Timothy Stenzel, M.D., Ph.D. from the Food and Drug Administration (FDA) review the process, procedures, and challenges related to evaluating test performance and authorizing products—specifically antibody tests—early in the pandemic. Their conclusion: “Moving forward, the FDA will continue to take steps to ensure the timely availability of accurate and reliable antibody tests to meet the public health need as the pandemic evolves.”

 

Jeffrey Shuren, M.D., J.D., and Timothy Stenzel, M.D., Ph.D. from the Food and Drug Administration (FDA) review the process, procedures, and challenges related to evaluating test performance and authorizing products—specifically antibody tests—early in the pandemic. Their conclusion: “Moving forward, the FDA will continue to take steps to ensure the timely availability of accurate and reliable antibody tests to meet the public health need as the pandemic evolves.” 

Read the article. 

Author’s Conclusions: 

First, our experience with serology tests underscores the importance of authorizing medical products independently, on the basis of sound science, and not permitting market entry of tests without authorization. 

Second, the federal government should coordinate the preparation of a public–private research plan to address epidemiologic questions regarding disease spread and immunity at the beginning of an outbreak as part of its preparedness plan. 

Third, we should establish the capacity within or on behalf of the federal government to evaluate test performance before outbreaks occur so that independent evaluation can be performed quickly during an outbreak. 

Fourth, the scientific and medical communities should understand the purpose and clinical use of serology tests and how to appropriately use test results in general to inform patient care. 

Finally, all parties involved in public health emergency response need better information more quickly.

 

NEJM: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Using data from a phase 3 randomized, observer-blinded, placebo-controlled trial, conducted at 99 centers across the United States with over 30,000 volunteer enrollees, authors reveal the mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease. Aside from transient local and systemic reactions, no safety concerns were identified.

 

Using data from a phase 3 randomized, observer-blinded, placebo-controlled trial, conducted at 99 centers across the United States with over 30,000 volunteer enrollees, authors reveal the mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease. Aside from transient local and systemic reactions, no safety concerns were identified.

Read the article.

 

 

Monoclonal Antibody Authorization from the FDA (Updated 02/09/21) & MaineCare Reimbursement

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) this week for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) who test positive for SARS-CoV-2 and who are at high risk for progressing to severe COVID-19.

 

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19  (Guidance Document 02/11/21) 

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) this week for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) who test positive for SARS-CoV-2 and who are at high risk for progressing to severe COVID-19. The authorized use includes treatment for those who are 65 years of age or older or who have certain chronic medical conditions. 

Maine Care Claims for Monoclonal Antibody Product and Infusion Codes, CR 99700 (Updated 02/10/21) 

Providers of MaineCare Benefits Manual, Section 90 and Section 45 services may submit claims for the delivery of Monoclonal Antibody COVID-19 Infusion treatments when they are delivered on or after the respective effective dates for each product and in accordance with the for each product. 

Please review the Fact Sheets for Health Care Providers of EUA of Bamlanivimab and Casirivimab & Imdevimab for the limitations of authorized use. 

More information on various codes and their rates can be found here.

 

    

Guidance for Industry: Investigational COVID-19 Convalescent Plasma (Updated 02/11/20)

On August 23, 2020, FDA issued an Emergency Use Authorization (EUA) for COVID-19 convalescent plasma for the treatment of hospitalized patients with COVID-19.  The FDA recognizes that while COVID-19 convalescent plasma may be used under an EUA consistent with the authorization, COVID-19 convalescent plasma may also be used under an investigational new drug application (IND).

 

On August 23, 2020, FDA issued an Emergency Use Authorization (EUA) for COVID-19 convalescent plasma for the treatment of hospitalized patients with COVID-19.  The FDA recognizes that while COVID-19 convalescent plasma may be used under an EUA consistent with the authorization, COVID-19 convalescent plasma may also be used under an investigational new drug application (IND). 

For the purposes of this guidance, the term “COVID-19 convalescent plasma” refers to the convalescent plasma authorized under the EUA, while the term “investigational convalescent plasma” refers to convalescent plasma that does not meet all the conditions of the EUA and/or is being used under an IND. 

Read the Final Guidance Document, issued on February 11, 2021. It supersedes the guidance issued on January 15, 2021. 

The public may submit either electronic or written comments on FDA guidance at any time as follows: 

Electronic Submissions 

Submit electronic comments in the following way: 

Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov  will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov

If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission. 

Submit written/paper submissions as follows: Mail/Hand delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

 

 

Maine Legislative Leadership COVID-19 Bill Set for Public Hearing Tuesday

LD 1, An Act To Establish the COVID-19 Patient Bill of Rights is scheduled for a public hearing, this Tuesday, February 16 before the Joint Committee on Health Coverage, Insurance and Financial Services at 10:00 a.m.

 

LD 1, An Act To Establish the COVID-19 Patient Bill of Rights is scheduled for a public hearing, this Tuesday, February 16 before the Joint Committee on Health Coverage, Insurance and Financial Services at 10:00 a.m. 

The bill includes numerous pandemic policy issues, including: 

· Provider notice of costs for COVID-19 screening and testing. 

· Carrier coverage for health care services for COVID-19, including testing and immunizations. 

· Prescriptions during a state of emergency, including allowances for prescriptions to a patient a for an extended period of time, not to exceed a 180-day supply, during a state of emergency declared by the Governor. 

· Authorizes a pharmacist to administer and order COVID-19 vaccines licensed by the United States Food and Drug Administration that are recommended by the United States Centers for Disease Control and Prevention Advisory Committee on Immunization Practices for administration. 

· Language that would allow a clinician in charge (physician, ARPN, PA) at a point of dispensing site (that has an MOU with the State) to delegate authority to administer the COVID-19 vaccine to employees, staff, agents, or volunteers (subject to CDC training). 

· Anticipated workforce issues such as the licensing issues and obstacles raised by many retired MMA physician members ready and willing to volunteer help. 

· Authorizes the delivery of health care services through telehealth by audio-only telephone and requires payment parity by carriers for telehealth services. 

The bill is jointly sponsored by Maine Senate President, Troy Jackson (Allagash) and Maine House Speaker, Ryan Fecteau (Biddeford). MMA Government Affairs staff greatly appreciates the President’s and Speaker’s offices for their efforts to include Maine’s physician community in discussions on the bill prior to the public hearing. 

 

Next MMA Legislative Call Will Be Wednesday, February 17th

MMA Legislative Committee Chair, Jay Mullen, M.D. welcomes you to participate in the weekly conference calls of the MMA Legislative Committee.

 

MMA Legislative Committee Chair, Jay Mullen, M.D. welcomes you to participate in the weekly conference calls of the MMA Legislative Committee. 

The purpose of the weekly conference calls is to discuss the MMA's position on bills printed the previous week, to hear the views of specialty societies on the new bills or their concerns about any current health policy issues, and to discuss the highlights of legislative actions of the week. The calls rarely last longer than an hour. 

Legislative Committee members and specialty society legislative liaisons are strongly encouraged to participate. Any physician, practice manager, or other staff member who is interested in the MMA's legislative advocacy also is welcome to participate. It is not necessary to RSVP for the calls. 

The next MMA Legislative Committee weekly conference call for the First Regular Session of the 130th Maine Legislature will take place Wednesday, February 17th, at 7:00 p.m. via Zoom. 

You may now join the meeting with your computer or continue to connect by phone only. Please use the following Zoom meeting information. This will remain the same for every weekly call during the session. 

Legislative Committee Weekly Update Feb 17, 2021 7:00 PM 

Join Zoom Meeting: https://zoom.us/j/92954551629?pwd=WUF1L3BkMHY5SW1iYzhGSjdscGN6dz09

Meeting ID: 929 5455 1629

Passcode: 2021 

Dial by your location: +1 646 876 9923 US (New York) 

Find your local number: https://zoom.us/u/adD6zd4sZG

A list of the bills to be discussed during the weekly call will be e-mailed to committee members and those interested early next week.  If you would like to be added to this e-mail list, please contact Sarah Lepoff at  slepoff@mainemed.com.

 

Daniel Hanley Center for Health Leadership’s Renowned Physician Executive Leadership Institute – The Advanced Course Enrollment is OPEN

Enrollment is now under way for the Daniel Hanley Center’s sixth annual Physician Executive Leadership Institute—Advanced Course. Be sure to save your seat in the next cohort as we can only accept the first 35 physician enrollments!

 

Daniel Hanley Center for Health Leadership’s Renowned Physician Executive Leadership Institute – The Advanced Course Enrollment is OPEN for Cohort VII Commencing May 2021 Nomination 

Deadline: February 10, 2021 

Enrollment Deadline:  March 1, 2021 

To learn more: https://www.hanleyleadership.org/leadership-courses/physician-executive-leadership-institute/peli-advanced-course/ 

To nominate yourself or a colleague:  https://tinyurl.com/PELINominate 

To enroll:  https://tinyurl.com/PELIADV7 

Enrollment is now under way for the Daniel Hanley Center’s sixth annual Physician Executive Leadership Institute—Advanced Course. Be sure to save your seat in the next cohort as we can only accept the first 35 physician enrollments! 

Physicians enrolling in the program are designated as McAfee Fellows, in honor of former AMA and MMA President Robert McAfee, MD. Participants gain knowledge, skills and tools in the core competency areas of: systems awareness; strategic focus; key management/business skills; self-awareness; healthcare trends and teamwork and collaboration, best enabling them to lead and transform our healthcare delivery system. 

Here is what a few recent McAfee Fellows have shared about their PELI Advanced experience: 

“I can tell you with great certainty that I feel a lot more confident about my group decision making, my influence on a group’s behavior and my strategic planning. My ability as a leader is significantly enhanced by the PELI program. That is a given.” 

“Having another avenue to apply my energies, new unchartered territory, it’s exciting in a different way and I think that gives satisfaction that mitigates against some burnout stuff that could potentially happen.” 

“It exposes participants to other leaders, ideas, approaches and efforts.” 

Here is what a few recent CEO’s have shared about the value of supporting their physicians in the Advanced Course: 

"Benefit to health system – implementation of a new medical staff meeting format that increased attendance and focused on provider wellness: reduced burnout; improved provider engagement.” 

“With more confidence in their skills: one physician is capably developing a new team-based model of care in his practice; several physicians have moved into leadership positions; one physician has become a mentor of physicians who need skill development.” 

Over the past 8 years, nearly 200 physicians have participated in the Advanced Course. Our 7th cohort will begin May 6, 2021 and continue through March 26, 2022.  There are six two-day residential sessions, each running from Thursday evening through late Saturday morning. The Hanley Center is planning for the class to include 30-35 physician leaders from Maine, New Hampshire, and beyond. 

A distinguished five-member faculty team from the Heller School at Brandeis University delivers much of the course content for the Advanced Course, joining with Maine-based subject matter experts and physician leaders.  McAfee Fellows receive 80 hours of Category One CME for their participation in the full course.

To nominate yourself or a colleague:  https://tinyurl.com/PELINominate

To enroll, go to:  https://tinyurl.com/PELIADV7

To learn more, please contact me at:  judiannsmith@hanleyleadership.org (207-615-6253) or Janet LaFlamme at jlaflamme@hanleyleadership.org (207-553-9854).

PPE Available Through the MMA & ActionPPE

The Maine Medical Association is teaming with ActionPPE.org for access to PPE SUPPLIES for the safety of your patients, your staff, and communities!!

 

The Maine Medical Association is teaming with ActionPPE.org for access to PPE SUPPLIES for the safety of your patients, your staff, and communities!! 

ActionPPE.org is a nationwide organization started by a South Carolina county medical society president to help his colleagues get access to critical PPE supplies. It’s a nationwide platform of pooled resources to directly help physicians meet the needs of their practices and patients. 

Most importantly, ActionPPe.org is not just a source for PPE contacts but an actual ordering site with current and active distribution lines. You can place orders online and have them shipped directly to your offices. 

Product details and certificates the masks, gowns, face shields etc. are provided on the site. ORDER NOW! https://actionppe.org/3/mainemed/ 

Do not hesitate to contact Director of Communications and Government Affairs, Dan Morin with any questions or more information at (207) 838-8613 call/text, or dmorin@mainemed.com

 

 

                                                                                                                                                                                                                                                                                                                             

A Message from Maine Responds: Volunteer Opportunity

By registering with Maine Responds at maineresponds.org, you will join our listing of volunteers against which we search for any emergent volunteer workforce needs.

 

 A Message from Maine Responds:

We appreciate all of the offers coming in to assist in Maine CDC's COVID-19 response.  By registering with Maine Responds at maineresponds.org, you will join our listing of volunteers against which we search for any emergent volunteer workforce needs. Read on for the details of joining both Maine Responds, and our more involved volunteer opportunities through Maine Medical Reserve Corps - members of both start with the same first step: register at maineresponds.org.

The Maine Responds Emergency Health Volunteer System is the online registration system for public health, healthcare and emergency response volunteers for the State of Maine.

Maine Responds is a partnership that integrates local, regional, and statewide volunteer resources to assist our public health and healthcare systems. It is part of a national initiative to train, coordinate, and mobilize volunteers during an emergency. Maine Responds coordinates verified, pre-credentialed public health, healthcare and emergency response volunteers into a single database that can coordinate the need for volunteers across county, regional and state lines if needed.

Maine Medical Reserve Corps (MRC) volunteer programs reinforce our state's public health infrastructure and support low stress/no-fault exercise environments that test critical response capabilities.  Members of both Maine Responds and MRC start with the same first step: register at maineresponds.org. You will be able to select your local MRC unit in the drop-down menu under the "Organizations" section of the registration - refer to this link to determine your Public Health District(s).  Maine Responds ESAR-VHP is our volunteer communication and activation system.

Contact: Edward Molleo  edward.f.molleo@maine.gov

Public Health Emergency Preparedness
Department of Health and Human Services
Maine Center for Disease Control and Prevention

Maine Legislature Week 5 Update

The following is a summary of happenings during week 5 of the Maine Legislature.

 

Health and Human Services Committee: 

Six different bills of interest to MMA were heard this week. 

The committee held a number of those hearings on Tuesday. Two that take aim at the class of chemicals known as PFAS took place this week. LD 129, a bill from the Governor’s offices sponsored by state Senator, Trey Stewart (R-Presque Isle) would require schools, daycares and community water systems serving at least 15 customers to begin testing drinking water for various types of PFAS by Dec. 31, 2022. 

The second, LD 164 would create an upper limit of 20 parts per trillion for six types of PFAS. Special thanks are to Lani Graham, MD, for testifying. Dr Graham is former director of the Maine Bureau of Health (which became Maine CDC in 2005). She is widely recognized for her environmental health activism. Nobody works harder as a physician and patient advocate. Dr. Graham’s comments were included in a Portland Press Herald article covering the hearings (Health groups, affected families urge lawmakers to toughen Maine standards on ‘forever chemicals”). 

From the article: 

“Maine people have been confused and frightened to find their drinking water contaminated by PFAS at levels considered unacceptable in neighboring states,” said Dr. Lani Graham. A physician testifying on behalf of the Maine Medical Association, Graham also served on the state’s PFAS Task Force that examined the issues for much of 2019. 

Mary Tedesco-Schneck, a Pediatric Nurse Practitioner and an Assistant Professor at the University of Maine in the School of Nursing offered a potential amendment on behalf of Maine Chapter of the American Academy of Pediatrics. 

Also heard Tuesday, LD 206 regarded reviewing the lead testing in school drinking water. The bill proposed one-time testing of all schools in the state, after flushing the system and holding the water for 8-18 hours. The level of lead for the state of Maine was set at 15 ppb. Three were in support of the bill, however, they were in support because it would further efforts to test school drinking water but noted the need for stricter measures. 

Mary Tedesco-Schneck, again testified in support on behalf of Maine Chapter of the American Academy of Pediatrics. Four were in opposition and two were neither for nor against. A work session for LD 206 is not yet scheduled. 

LD 47, An Act to Fund the State’s Free Health Clinics was heard on Wednesday. Twenty-four pieces of testimony were received by the committee, all in support of providing $500,000 in one-time funding to six free health clinics in the State. The strongest oral support came from three free clinics, Portland Community Free Clinic, Oasis Free Clinics Brunswick Maine, and Knox Clinic, as they give needed services to those who do not qualify for State insurance. President of the Board of the Friends of the Portland Community Free Clinic (FPCFC), Caroline Teschke, MD, provided vocal testimony in support and deftly answered numerous information and data questions from committee members. The MMA also testified in support of the bill. A work session for this bill is scheduled for Thursday, February 18th, at 10:00. 

The last bill heard was LD 118, An Act to Address Maine’s Shortage of Behavioral Health Services for Minors. The Maine Hospital Association priority bill proposes gathering data on the number of children in hospitals for long-term behavioral health stays. Eight were in support, most commonly noting the limited services available for children with behavioral health needs and the lack of resources. One in opposition, of the Office of Child and Family Services, was concerned about the workload this would put on caseworkers who could otherwise provide direct services to those in need. They also noted the need for more services in addition to more data. 

Maine Chapter of the American Academy of Pediatrics, President Deborah Hagler, MD, FAAP and MAAP Board Member, Jennifer Jewell, MD, MS, FAAP provided joint testimony in support. 

Jeff Austin from the Maine Hospital Association commented the committee in charge should be the Children’s Alliance rather than the legislative committee, for their expertise and experience on the issue. 

Education and Cultural Affairs: 

One bill was heard, LD 104, An Act To Protect the Health of Student Athletes by Requiring the Establishment of Procedures To Report Concussions. This bill would require schools to gather data on sports-related concussions and submit this data to a statewide database. The committee was most concerned with current data tracking in the State such as the Head Injury Tracking App (HIT) and how this could be utilized. They were also concerned with the potential privacy issues and the narrowness of the bill. 

Two were in support, explaining the need to understand concussions for potential health risks. One was in opposition, they were concerned with who would be tracking the data, as many schools do not have full-time trainers and thus data tracking would fall on coaches or school nurses. The large question of this bill is why it only includes sports-related concussions. The answer provided during the hearing was that gathering all the data would be a large step from having no aggregated data.  The work session scheduled for Wednesday, February 17th, at 10:00 am. 

Committee on Health Coverage, Insurance and Financial Services: 

The Committee, on Tuesday, held public hearings on LD 46 and LD 60; MMA testified neither for nor against both bills.  LD 46, which makes some changes to Maine’s surprise billing law, was supported by three and had no opposition. MMA recommended a documented and clearly identified process for selection of an alternate medical claims database, should MHDO data be insufficient. 

LD 60, requiring pharmacists to dispense at least a 30-day supply of insulin in emergency situations, was met with mixed support. On behalf of MMA, Dan Morin recommended an amendment to limit emergency dispensation to once a year and for committee members to strongly consider appropriate notice to primary care medical practices when emergency dispensations are given to their patients by pharmacists. 

On Thursday, the Committee held a public hearing on LD 167 and LD 367, both of which prohibit a health care provider from billing a patient, or giving a patient notice of a bill, once six months have passed since the date of service.  MMA’s Dan Morin, along with several other organizations, testified in opposition to both bills, noting several occasions where adjudication takes more than six months. Mr. Morin also noted the likeliness of increased confusion for patients, increased calls to customer service and billing departments, and increased administrative costs. Finally, Thursday also saw a hearing on LD 178, An Act to Reduce Waste of Prescription Medications. For several reasons, as outlined in the testimony itself, MMA opposed the bill. 

The Maine Legislature Week Five Update was drafted by MMA Legislative Session Interns, MiKenzie Dwyer (UNE Senior) and Matt Fortin (Maine Law 2L) 

Please contact MMA Director of Communications and Government Affairs, Dan Morin at dmorin@mainemed.com or by phone at 207-480-4199 for a copy of the amended bill, or more information on the bill, and potential comments and suggestions you may wish us to include with our public comments in support of the bill.

  

 

 

Upcoming Public Hearings & Work Sessions; New Bills Introduced

 The following bills of interest to MMA have been scheduled for public hearings and/or work sessions before legislative committees of policy jurisdiction. Also listed below are new bills of interest printed this week being monitored and considered by the MMA Legislative Committee and MMA Board of Directors. They will potentially be reviewed and discussed during MMA’s weekly MMA Legislative Policy Feedback Call this Wednesday.
 

The following bills of interest to MMA have been scheduled for public hearings and/or work sessions before legislative committees of policy jurisdiction. Also listed below are new bills of interest printed this week being monitored and considered by the MMA Legislative Committee and MMA Board of Directors. They will potentially be reviewed and discussed during MMA’s weekly MMA Legislative Policy Feedback Call this Wednesday. 

Week of February 15—February 19 

Tuesday, February 16, 2021 

10:00 AM—Health Coverage, Insurance and Financial Affairs 

LD1 An Act To Establish the COVID-19 Patient Bill of Rights—(MMA Support) 

LD 274 Resolve, Directing the Maine Health Data Organization To Determine the Best Methods and Definitions To Use in Collecting Data To Better Understand Racial and Ethnic Disparities in the Provision of Health Care in Maine—MMA Monitor 

11:00 AM –Health Coverage, Insurance and Financial Affairs (Work Session) 

LD 178, An Act to Reduce Waste of Prescription Medications—(MMA Opposed) 

1:00 PM – Appropriations and Financial Affairs (Biennial State Budget Hearing for Maine DHHS) 

LD 221, An Act Making Unified Appropriations and Allocations for the Expenditures of State Government, General Fund and Other Funds and Changing Certain Provisions of the Law Necessary to the Proper Operations of State Government for the Fiscal Years Ending June 30, 2021, June 30, 2022 and June 30, 2023—(Provision Opposed by MMA) 

Wednesday, February 17, 2021 

10:00 AM—Education and Cultural Affairs (Work Session) 

LD104 An Act To Protect the Health of Student Athletes by Requiring the Establishment of Procedures To Report Concussions—(MMA Support) 

1:00 PM – State and Local Government (Work Session) 

LD 2, An Act to Require the Inclusion of Racial Impact Statements in the Legislative Process—(MMA Support) 

Thursday, February 18, 2021 

10:00 AM—Health Coverage, Insurance and Financial Affairs 

LD 254 An Act To Allow Certified Registered Nurse Anesthetists To Bill for Their Services—(MMA Monitor) 

LD 295 An Act To Repeal Restrictions That Prohibit Certain Advanced Practice Registered Nurses from Providing Essential Health Care Services—(MMA Opposed) 

10:00 AM –Health and Human Services (Work Session) 

LD 47, An Act to Fund the State’s Free Health Clinics—(MMA Support) 

New Bills 

LD 423An Act To Improve Access to Bariatric Care in Nursing Homes Summary: This bill requires DHHS to provide bariatric care centers embedded in nursing facilities to provide requisite care within the nursing facility setting. 

LD 429, An Act To Protect the Health of Students and Educators by Requiring the Establishment of Health and Safety Committees in School Administrative Units Summary: This bill requires each school administrative unit to establish a health and safety committee to coordinate planning and response to health and safety matters affecting students and staff, and prioritizes COVID-19 response while a state of emergency is in effect. 

LD 432, Resolve, To Improve Behavioral Health Care for Children Summary: This resolve requires DHHS to amend rule Chapter 101 of the MaineCare Benefits Manual to reimburse for additional collateral contacts for children’s home and community-based treatment, then lists the contacts. 

LD 441, An Act To Expand Adult Dental Health Insurance Coverage Summary: This requires health insurance carriers to provide coverage for dental services and for MHDO to develop and maintain a publicly accessible database of dentists providing dental care to MaineCare members. 

LD 450 An Act To Promote the Education of Patients by Primary Care and Urgent Care Physicians Regarding the Bone Marrow Transplant List One-Liner: Requires the Department of Health and Human Services to develop and disseminate information and educational materials about bone marrow donation to the public and health care providers. 

LD 476 An Act To Provide Licensed Assisted Living and Nursing Facilities Levels of Care for Incarcerated Persons One-Liner: Provides levels of care for assisted living, nursing facilities, and correctional facilities along with an assessment of medical and social needs of prisoners using the Medicaid eligibility assessment. 

Please contact MMA Director of Communications and Government Affairs, Dan Morin at dmorin@mainemed.com or by phone at 207-480-4199 for a copy of the amended bill, or more information on the bill, and potential comments and suggestions you may wish us to include with our public comments in support of the bill.

Upcoming Specialty Society Meetings

Below you will find an on-going list of Upcoming Specialty Society Meetings. Any questions should be referred to the contact person listed for each specialty.

 

Below you will find an on-going list of Upcoming Specialty Society Meetings.  Any questions should be referred to the contact person listed for each specialty.

UPCOMING SPECIALTY SOCIETY MEETINGS

February 27, 2021
Maine Society of Anesthesiologists Business Meeting

Virtual Meeting - 2:00pm - 5:00pm
Contact:  Lisa Montagna 207-620-4015 or mesahq@gmail.com

April 15, 2021
Maine Association of Psychiatric Physicians Annual Meeting
Virtual Meeting - 6:00pm - 8:00pm
Contact: Dianna Poulin 207-622-7743 or dpoulin@mainemed.com

May 1-2, 2021
Maine Chapter, American Academy of Pediatrics Virtual CME Spring Conference

The Impact of Social Determinants of Health and ACE's:
The Provider Role in Mitigating Risk and Promoting Resilience in Youth

Contact:  Dee Kerry 207-620-0806 or dkerry@maineaap.org

May 7, 2021
Maine Society of Eye Physicians and Surgeons Spring Meeting

Virtual Meeting
Contact:  Shirley Goggin 207-445-2260 or sgoggin@mainemed.com

May 21-22, 2021
29th Annual MAFP Family Medicine Update & Annual Meeting

Virtual Meeting
Full brochure and registration available after February 15, 2021 at www.maineafp.org
Contact: Deborah Halbach 207-938-5005 or maineafp@tdstelme.net

 

 

 

 

 

 

  


 

Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions

CDC physicians, and MMA members, Stephen Sears, M.D, MPH, and Lisa Letourneau M.D., MPH will be hosting a series of 30-minute Clinician Info Sessions twice weekly (Tuesdays and Fridays) for the next couple of months to provide key information on the emerging COVID-19 vaccines & offer an opportunity for Q&A with clinicians statewide.

 

CDC physicians, and MMA members, Stephen Sears, M.D, MPH, and Lisa Letourneau M.D., MPH will be hosting a series of 30-minute Clinician Info Sessions twice weekly (Tuesdays and Fridays) for the next couple of months to provide key information on the emerging COVID-19 vaccines & offer an opportunity for Q&A with clinicians statewide. 

The sessions will start, Tuesday, December 15 and take place at 7:30 a.m., Tuesdays and 12 noon, Fridays until further notice. 

Dr. Sears is an epidemiologist & Maine CDC Clinical Advisor for the COVID-19 Response Team, while Dr. Letourneau is Senior Advisor for Delivery System Change at the Maine Department of Health and Human Services. We hope you’ will l take advantage of this opportunity to join these two well respected experts. 

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> 

Join Zoom Meeting https://zoom.us/j/6218434986?pwd=dEJoNEVRSkVSN2dwZlJ5WEl3WjJsZz09 

Meeting ID: 621 843 4986 

Passcode: 338847 

One tap mobile: +13017158592,,6218434986#,,,,,,0#,,338847# 

AMA Designation Statement The Maine Medical Education Trust designates each Live Internet activity session for a maximum of .5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Joint Providership Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and the Maine Department of Health and Human Services. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.

 

 

Suicide Prevention and Management in Healthcare Practice Settings: A Comprehensive Evidence-Based Approach

NAMI Maine is now scheduling this presentation for healthcare practice settings.

 

Suicide Prevention and Management in Healthcare Practice Settings: A Comprehensive Evidence-Based Approach
Presented by Greg Marley, LCSW - Director of Suicide Prevention, NAMI Maine

For more information and to schedule a presentation, contact the NAMI Maine Suicide Prevention Coordinator at mspp@namimaine.org or at (800) 464-5767 x2318.

A Maine citizen is 13.5 times more likely to die by suicide than by homicide (2016-2018), yet suicide is among the most preventable forms of death.  Healthcare practice settings provide an excellent venue for the identification and assessment of suicide risk and the provision of ongoing care to assist in the management of the drivers of suicide.

This 1-hour presentation will provide updated information on trends in suicidal behavior across the lifespan and an overview of the best-practice approach to suicide identification, assessment, and management of suicide within a practice or hospital setting.  Tools for practice will be offered to address assessment, Collaborative Safety Planning and coordinated follow-up.  This presentation is appropriate to any professional working in a medical, clinical or behavioral health role: medical providers, nurses, social workers and ancillary clinicians and support staff.

Attendees will leave able to

  • Articulate the rationale for a structured approach to suicide assessment and management in healthcare
  • Describe to elements of suicide assessment and Collaborative Safety Planning
  • Appreciate the recent trends in suicide across the lifespan in Maine

In collaboration with the Maine Suicide Prevention Program and NAMI Maine, the Maine Medical Association offers resources for physicians and medical practices at www.mainemed.com/suicide-prevention.


AMA Designation Statement: The Maine Medical Education Trust designates this live internet activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Joint Providership Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and NAMI Maine.  The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide Continuing Medical Education (CME) for physicians.


 

MOA VIRTUAL Midwinter Symposium - February 12th-14th

The Maine Osteopathic Association has opened Early Bird Registration for its VIRTUAL Midwinter Symposium, being held February 12-14, 2021.


The Maine Osteopathic Association has opened Early Bird Registration for its VIRTUAL Midwinter Symposium, being held February 12-14, 2021

The MOA program committee has been hard at work to ensure the Midwinter Symposium is even better than the Annual Convention this past June. With 20+ AOA 1-A and AMA credits expected, you will not want to miss it! By registering early, you can save yourself $50 and MOA members get a special member rate. (Students & Residents, your registration is complimentary, we just ask you do please register!) To register, please visit our Midwinter Symposium Event Page. Cannot remember your password? Don't worry, you will be able to quickly reset it so you will be able to take a peek around the MOA's new "home". Just follow the "Forgot Password" link. (BONUS: once logged in, most of the registration fields  for the Midwinter will auto-populate, making registration easy-peasy). 

We are delighted to be hosting the first ever ONLINE Silent Auction this year, to benefit the Maine Osteopathic Education Foundation. In true tradition, we host the Silent Auction each February in conjunction with the Midwinter Symposium at the Holiday Inn by the Bay in Portland. This year, we will offer the same great fundraiser for MOEF, just virtually based. With it being offered online, it  broadens our audience beyond those in attendance at the conference, to anyone within the MOA network and beyond. The auction will run from February 11-13th and you will be able to view the auction gifts in advance of the auction going "Live", make donations and bid on some great items. We are also collecting donations now if you or anyone you know, might be interested in donating goods, gift cards or services. 

Save the Date!  

If you are interested in becoming a sponsor or exhibitor with us for the Midwinter Symposium, check out these great resources now to learn more

We look forward to this great event,  please feel free to email the MOA with any questions or concerns! 

 

Maine CDC Annual Prevention Professionals Conference - March 2nd-3rd

The health and safety of Maine prevention professionals is our first priority, for this reason the Prevention Professionals Conference planned for October 2020 has been rescheduled to March 2 & 3, 2021. The conference will be held virtually over two days.

 

Save the Dates: March 2 & 3 - The conference content will be delivered virtually over two days. 

The health and safety of Maine prevention professionals is our first priority, for this reason the Prevention Professionals Conference planned for October 2020 has been rescheduled to March 2 & 3, 2021. The conference will be held virtually over two days. 

The conference planning committee is working hard to reevaluate the needs of prevention professionals across the state. The committee is particularly interested in centering this event around exploring and addressing diversity, equity, and inclusion within public health prevention services in Maine. 

We would love to hear directly from you all what would be most helpful in this unpredictable time, please take a couple of minutes to let us know your thoughts: https://www.surveymonkey.com/r/PPCCOVID

Please be on the lookout for additional information and registration information. Thank you for your patience! Stay well!

 

AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)

The recently revised EQIPP immunization course is designed to identify immunization rates in your practice, uncover barriers to immunization delivery systems, and provide techniques to overcome those barriers using clear aims that reflect expert principles and proven quality improvement methods and tools.

 

The recently revised EQIPP immunization course is designed to identify immunization rates in your practice, uncover barriers to immunization delivery systems, and provide techniques to overcome those barriers using clear aims that reflect expert principles and proven quality improvement methods and tools. 

The online course features two tracks; the 19–23-month-old track and the adolescent track with data collection activities specific to each population. The course is eligible for PI CME, NAPNAP, MOC Part 2, and MOC Part 4 credits. 

The course is free to AAP members - and for a limited time, is being offered free to ALL rural health clinicians in Maine (Pediatricians AND Family Practice) through an AAP initiative.  Additional course information is available here

For rural health care providers that are non-AAP members and interested in taking this immunization course, contact Melissa Ponce at mponce@aap.org for additional information and to have your course fee waived through the Supporting Pediatricians to Improve HPV and Pediatric Influenza Vaccination Rates Initiative - again, the EQIPP immunization course is open to all Maine physicians serving youth, and the course fee is being waived for ruralhealth clinicians!

Physician (BC/BE in Family Medicine)

Mt. Abram Regional Health Center, (Kingfield, Maine) seeks a Physician (BC/BE in Family Medicine) with outstanding clinical and interpersonal skills to provide primary care to patients of all ages in a family practice with integrated behavioral health services.

Mt. Abram Regional Health Center, (Kingfield, Maine) seeks a Physician (BC/BE in Family Medicine) with outstanding clinical and interpersonal skills to provide primary care to patients of all ages in a family practice with integrated behavioral health services. An X waver would be desirable. The selected candidate will receive a $5,000 sign-on bonus, competitive salary and benefits, malpractice coverage, pension plan with employer match, loan repayment opportunities. EOE.

Mt. Abram Regional Health Center resides in the welcoming community of Kingfield near Sugarloaf USA and the University of Maine (Farmington). It is part of HealthReach Community Health Centers, a system of eleven practices in central and western Maine. Medical clinicians at Mt. Abram benefit from collaborative relationships with HealthReach clinicians as well as colleagues at Franklin Memorial Hospital in Farmington.

Mt. Abram Regional Health Center is part of HealthReach Community Health Centers, a system of 11 Federally Qualified Health Centers in Central and Western Maine with a 45-year history offering accessible, high quality healthcare with integrated behavioral health, psychiatric medication management, and referrals. HealthReach accepts Medicare, MaineCare and major insurances and a sliding fee program is available to uninsured and underinsured residents as well as assistance with applications for programs that help with the cost of health care and medications including the Health Insurance Marketplace.

Contact: Recruiter, HRCHC, 10 Water Street, Suite 305, Waterville, ME 04901 | 207-660-9913 | Fax: (207) 660-9901 | Communications@HealthReach.org | www.MtAbramCHC.org

2/11/20

Nursing Director

Nasson Health Care is seeking a qualified clinical leader to work collaboratively with a team of health and administrative professionals to provide comprehensive primary care to patients while utilizing the Patient-Centered Medical Home model of care delivery. 

Nasson Health Care is seeking a qualified clinical leader to work collaboratively with a team of health and administrative professionals to provide comprehensive primary care to patients while utilizing the Patient-Centered Medical Home model of care delivery.  The Nursing Director:

  • Oversees clinical support services, including primary care support, care management and community health work.
  • Collaborates with members of the practice team to identify and manage the care of patients with high-risk and complex conditions utilizing established care management criteria.

Qualifications include:

  • A Master’s degree in nursing, health care management or related field required.
  • A Maine Registered Nurse license.
  • A minimum of three years’ supervisory experience in a health care delivery setting.

Visit www.yccac.org for an application. Completed cover letter, resume, and YCCAC employment application will be accepted until February 26, 2021.

York County Community Action Corp.
6 Spruce Street, P.O. Box 72
Sanford, ME 04073
(207) 324-5762 or 1-800-965-5762
Fax (207)459-2811

apply@yccac.org

EOE

3/4/21

Medical Director - Bucksport Regional Health Center

As an integrated center we are seeking a Medical Director to oversee the structure/scope of our clinical program, provide supervision to physicians, and other clinical providers, lead quality improvement activities and provide ambulatory/primary care for patients.

Enjoy the beautiful coast of Maine - Bucksport Regional Health Center – a  community health center serving Bucksport, Maine and the surrounding communities with two locations, Bucksport and Ellsworth, Maine.  We have 78 employees and 16 providers (varying hours).  As an integrated center we are seeking a Medical Director to oversee the structure/scope of our clinical program, provide supervision to physicians, and other clinical providers, lead quality improvement activities and provide ambulatory/primary care for patients.  WE OFFER A SALARY COMPETITIVE TO THE HOSPITAL SETTING!

  • Board Certified Physician (MD or DO)
  • Licensure in Maine preferred or willingness to become Maine licensed
  • 7-10 years family practice or internal medicine
  • 5 years experience direction medical services
  • Strong EMR background

Submit resume to dadams@brhcme.org

2/11/21

Rangeley Family Medicine seeks Physician

Rangeley Family Medicine seeks a Physician to:

  • Engage patients in improving their wellbeing.
  • Participate in a team of clinicians serving a network of 11 family practices.
  • Serve people of all ages and economic situations.
  • Develop a common treatment plan with behavioral clinicians to address physical/behavioral needs.
  • Live/work in spectacular setting with shimmering lakes, mountain views, verdant forests, abundant wildlife, 4-season family escapades.

Rangeley Family Medicine seeks a Physician to:

  • Engage patients in improving their wellbeing.
  • Participate in a team of clinicians serving a network of 11 family practices.
  • Serve people of all ages and economic situations.
  • Develop a common treatment plan with behavioral clinicians to address physical/behavioral needs.
  • Live/work in spectacular setting with shimmering lakes, mountain views, verdant forests, abundant wildlife, 4-season family escapades.

Compensation:

  • Competitive salary and benefit package
  • SIGN-ON BONUS - $10,000
  • Student loan repayment opportunities
  • Relocation ~ Malpractice coverage
  • Continuing education: $2,500 - 1 week per year
  • PTO - 272 hours annually
  • Retirement plan with employer match up to 2% of salary

Practice Details: 5-day week ~ 40 hours per week

Requirements: BC/BE in Family Medicine ~ Maine license

Contact: HealthReach Community Health Centers, 10 Water Street, Suite 305, Waterville, ME 04901 ~ (207) 660-9913 ~ Fax: (207) 660-9901 communications@HealthReach.org

HealthReach Community Health Centers is a group of eleven Federally Qualified Health Centers in Central and Western Maine. As NCQA certified Patient-Centered Medical Homes, we offer accessible, high quality healthcare with integrated behavioral health, psychiatric medication management, and referrals. To ensure access for everyone, HealthReach accepts Medicare, MaineCare and major insurances. In addition, a sliding fee program is available to uninsured and underinsured residents as well as assistance with applications for programs that help with the cost of health care and medications including the Health Insurance Marketplace. A private, non-profit with a 46-year history, HealthReach is funded by patient fees, grants, and individual donations.

2/25/21